Gilead Sciences

Hetero inks licensing agreement with Gilead for manufacturing, distribution of remdesivir

Domestic pharma major Hetero on Wednesday said it has entered into a licensing agreement with Gilead Sciences Inc for manufacturing and distribution of remdesivir, a potential therapy for COVID-19

India's Jubilant Life inks licensing agreement with Gilead to manufacture Remdesivir, a potential drug to treat COVID-19

Jubilant Life Sciences Ltd on Tuesday said it has entered into a non-exclusive licensing agreement with Gilead Sciences, Inc that will grant it the right to register, manufacture and sell the latter's investigational drug, remdesivir

Gilead ties up with 5 generic drugmakers in India, Pakistan for COVID-19 drug supply; licensees to set price for product

Gilead’s antiviral drug remdesivir earlier this month received the US Food and Drug Administration’s emergency use authorization to treat COVID-19 patients.

Four things you need to know about Remdesivir, the FDA-approved drug for severe COVID-19 cases

Remdesivir is a broad-spectrum antiviral medicine that has got significant public attention for its possible benefits in the treatment of COVID-19.

US Food and Drug Administration allows emergency use of intravenous drug Remdesivir for patients hospitalised with COVID-19

The Food and Drug Administration cleared Gilead Science’s Remdesivir for hospitalised patients with “severe disease,” such as those experiencing breathing problems requiring supplemental oxygen or ventilators.

Coronavirus Outbreak: US president Donald Trump and Anthony Fauci see hope in Gilead's drug Remdesivir

Dr Anthony Fauci, though, told reporters during a White House meeting with Donald Trump that the data on the drug, Remdesivir, needs to be further analysed.

Gilead's anti-viral drug Remdesivir succeeds in coronavirus treatment trial, company says medicine will prove helpful if given early

Gilead Sciences Inc’s experimental antiviral drug remdesivir helped improve symptoms in COVID-19 patients who were given the drug early than among those who were treated later, the company said.

Gilead rubbishes claim that antiviral drug, Remdesivir, failed to help Coronavirus patients in Chinese trial

Doctors suggest antiviral drugs would be most effective when administered as early as possible as it helps keep the virus from replicating in the blood.

Coronavirus Outbreak: Leaked results of a clinical trial hints Gliead's Remdesivir could be possible COVID-19 cure

During the trial, 113 patients were treated with the drug, most were discharged from the hospital in under a week, and only two died.

Stock market gains alongside economic pain driven by massive boost from Fed; some worry about over-optimism

The US stock market has changed its mood swiftly since 23 March—when the S&P 500 dropped as much as 35 percent below its 19 February peak.